Cadence Neuroscience Secures $15 Million in Series A Financing for Commercialization of Epilepsy Therapy Licensed from Mayo Clinic

REDMOND, Wash., Nov. 6, 2019 -- (Healthcare Sales & Marketing Network)-- Cadence Neuroscience announced today that it has secured $15 million in Series A financing. The round was led by JAZZ Venture Partners, with additional support being provided by May...Devices, Neurology, Venture Capital
Cadence Neuroscience, Epilepsy